The Discounted Cash Flow (DCF) valuation of NexgenRx Inc (NXG.V) is 0.21 CAD. With the latest stock price at 0.30 CAD, the upside of NexgenRx Inc based on DCF is -28.5%.
Based on the latest price of 0.30 CAD and our DCF valuation, NexgenRx Inc (NXG.V) is a sell. selling NXG.V stocks now will result in a potential gain of 28.5%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.8% | 6.7% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 0.18 - 0.27 | 0.21 |
| Upside | -40.7% - -8.4% | -28.5% |